Resection and survival data from a clinical trial of glioblastoma multiforme‐specific IRDye800‐BBN fluorescence‐guided surgery

Author:

He Kunshan12,Chi Chongwei2,Li Deling34,Zhang Jingjing5,Niu Gang6,Lv Fangqiao7,Wang Junmei8,Che Wenqiang34,Zhang Liwei34,Ji Nan34,Zhu Zhaohui5,Tian Jie12,Chen Xiaoyuan6ORCID

Affiliation:

1. Beijing Advanced Innovation Center for Big Data‐Based Precision Medicine Beihang University Beijing China

2. CAS Key Laboratory of Molecular Imaging, Institute of Automation Chinese Academy of Sciences Beijing China

3. Department of Neurosurgery, Beijing Tiantan Hospital Capital Medical University Beijing China

4. China National Clinical Research Center for Neurological Diseases (NCRC‐ND) Beijing China

5. Department of Nuclear Medicine, Peking Union Medical College Hospital Chinese Academy of Medical Sciences and Peking Union Medical College Beijing China

6. Laboratory of Molecular Imaging and Nanomedicine (LOMIN) National Institute of Biomedical Imaging and Bioengineering (NIBIB), National Institutes of Health (NIH) Bethesda Maryland USA

7. Department of Cell Biology, School of Basic Medical Sciences Capital Medical University Beijing China

8. Department of Neuropathology, Beijing Neurosurgical Institute Capital Medical University Beijing China

Funder

Beijing Tian Tan Hospital, Capital Medical University

China Postdoctoral Science Foundation

Chinese Academy of Sciences

National Natural Science Foundation of China

Beijing Nova Program

Publisher

Wiley

Subject

Pharmaceutical Science,Biomedical Engineering,Biotechnology

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3